CYTK
Cytokinetics Inc
65.60$
+0.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +241.7% | -63.2% | +3.2% | +0.2% | -1.2% | -3.5% | -0.7% | +17.2% | +6.8% | +18.1% | +7.5% | – | |
| – | +4.1% | +10.9% | +13.9% | +3.0% | +3.5% | -10.3% | +16.9% | +11.5% | -0.6% | -0.4% | +17.5% | – | |
| – | +2,930.3% | -157.3% | – | +1.2% | +322.0% | -112.5% | – | – | -108.2% | – | – | – | |
| – | -65.0% | +2,177.9% | +9.2% | +28.2% | -47.5% | +339.1% | -26.8% | +125.7% | -39.7% | +5.1% | -26.9% | – | |
| – | -211.5% | – | -2,096.1% | -93.1% | – | -4.4% | -50.1% | -234.2% | +0.3% | – | -448.5% | – | |
| – | – | +98.0% | – | – | – | – | – | +48.2% | – | – | – | – | |
| – | – | – | – | – | +0.7% | -1.0% | -6.4% | – | -100.8% | +0.5% | +31.4% | – | |
| – | +211.3% | -38.5% | +691.0% | -99.6% | -30.4% | +99.4% | +1,551.9% | +320.8% | -66.5% | -93.0% | +10,104.1% | – | |
| – | -57.1% | -47.9% | +909.3% | -304.2% | – | -144.1% | – | +5,990.9% | -167.7% | – | +1,613.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.